Brevan Howard Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$485K	Buy	+11,107	New	+$485K	﹤0.01%	1280
2024 Q1	–	Sell	-14,208	Closed	-$362K	–	1134
2023 Q4	$362K	Buy	+14,208	New	+$362K	﹤0.01%	588